Transcode Therapeutics

/Transcode Therapeutics

IPO

Transcode Therapeutics

Biotechnology

TransCode Therapeutics is an emerging RNA oncology company, created on the belief that cancer can be defeated through the intelligent design and effective delivery of RNA therapeutics.

Symbol

RNAZ

Price Range
$4.00 - $4.00

Final Shares
6,250,000

Anticipated Date
May 14, 2021

Underwriters
FORDHAM FINANCIAL MANAGEMENT, INC.

This offering is no longer available

To view the prospectus for Transcode Therapeutics IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange